MERILOG

Sanofi-Aventis U.S. LLC🇺🇸 United States

FDA Page

Effective Date: May 30, 2025
Approval ID: eee07a52-1102-4d48-9782-26061db175ad
Products: 2 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar to NOVOLOG (insulin aspart).

Quick Stats

Total Products2

Labelers1

Label Sections42

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.